Oz MC, Goldstein DJ, Pepino P., et al. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation. 1995; 92(9 Suppl):169-173.
2.
Kohl BA, Horak J.Ventricular assist devices: a primer for the intensivist. Contem Clin. 2006;3(12):1-12.
3.
Samuels LE, Darze ESManagement of acute cardiogenic shock. Cardiol Clin . 2003;21(1):43-49.
4.
Goldberg RJ, Samad NA, Yarzebski J., et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340(15):1162-1168.
5.
Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?J Am Coll Cardiol . 2000;36(3 suppl A):1123-1129.
6.
Chen JM, DeRose JJ, Slater JP, et al. Improved survival rates support left ventricular assist device implantation early after myocardial infarction. J Am Coll Cardiol. 1999;33(7):1903-1908.
7.
Leshnower BG , Gleason TG, O’Hara ML, et al. Safety and efficacy of left ventricular assist device support in postmyocardial infarction cardiogenic shock. Ann Thorac Surg. 2006;81(4):1365-1371.
8.
Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction- etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?J Am Coll Cardiol. 2000;36(3 suppl A): 1063-1070.
9.
DeRose JJ , Umana JP, Argenziano M., et al. Improved Results for Postcardiotomy Cardiogenic Shock With the Use of Implantable Left Ventricular Assist Devices . Ann Thorac Surg. 1997;64(6):1757-1762.
10.
Jurmann MJ, Siniawski H., Erb M., Drews T., Hetzer R.Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg. 2004;77(5):1642-1647.
11.
Jett GKAbiomed BVS5000: experience and potential advantages. Ann Thorac Surg . 1996;61(1):301-304.
12.
Helman DN, Morales DLS, Edwards NM, Mancini DM, et al. Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg . 1999;68(4):1187-1194.
13.
Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg. 1999;14(4):288-293.
14.
Buckley MJ, Mundth ED, Daggett WM, DeSanctis RW, Sanders CA, Austen WGSurgical therapy for early complicationsof myocardial infarction. Surgery. 1971; 70(6):814.
15.
Gold HK, Leinbach RC, Sanders CA, Buckley MJ, et al. Intraaortic balloon pumping for ventricular septal defect or mitral regurgitation complicating acute myocardial infarction. Circulation. 1973;47(6):1191.
16.
Radford MJ, Johnson RA, Daggett WM, et al. Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival. Circulation. 1981;64(3):545-553.
17.
Deng MC, Loebe M., El-Banayosy A., Gronda E., et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation. 2001;103(2):231-237.
18.
Frazier OH, Rose EA, Oz MC, Dembitsky W., et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation . J Thorac Cardiovasc Surg. 2001;122(6):1186-1195.
19.
Hernandez AF , Grab JD, Gammie JS, O’Brien SM, et al. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons’ National Cardiac Database. Circulation. 2007;116(6):606-612.
